Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Trump’s US FDA User Fee Cycle: ‘An Underappreciated Threat’
Nov 16 2024
•
By
Sarah Karlin-Smith
President-elect Trump did not have full control of a user fee cycle during his first term, but will during his upcoming second term.
(Shutterstock)
More from User Fees
More from Elections